Hiroshi Ikeda

Prof. Hiroshi Ikeda

Biomaterials, Kyushu Dental University, Kitakyushu, Japan
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2014 in Ionics
Verified
Journal Article
Open access
PDF file
NMNorio Miura
Norio Miura
TSTomoaki Sato
Tomoaki Sato
SASri Ayu Anggraini
Sri Ayu Anggraini
HIHiroshi Ikeda
Hiroshi Ikeda
SZSerge Zhuiykov
Serge Zhuiykov
A robust and reliable gas sensing device is considered as a convenient and practical solution for gas concentration monitoring that has become a mandatory requirement in different field of applications. For in situ hazardous gases detection, a mixed-potential type gas sensor has been regarded as a promising solid-state gas sensor. For the past three decades, there has been a significant progress in achieving high performance in mixed-potential type sensors. Therefore, this review is focused on reporting the development of mixed-potential type gas sensors with combined yttria-stabilized zirconia (YSZ) as the base solid electrolyte material and various classes of electrode materials for their potential utilization as a high-performance sensing electrode. The underlying sensing mechanism of a mixed-potential type YSZ-based sensor is elaborated here in detail. Transformation in design and configuration of this type of sensor is also covered in this report. In addition, recent progresses on mixed-potential type gas sensors development for detection of several target gases, such as carbon monoxide, hydrocarbons, nitrogen oxides, hydrogen, and ammonia, are reviewed. Strategies to improve the sensing characteristic, particularly gas sensitivity and selectivity, are also reported. Based on the understanding of the fundamental sensing mechanism and the requirements for high-performance gas sensors, challenges and future trends for this type of gas sensor development are discussed.

13 May 2011 in Hepatology
Verified
Journal Article
Open access
PDF file
HYHaruhiko Yoshida
Haruhiko Yoshida
YSYasushi Shiratori
Yasushi Shiratori
Masatoshi KudoMasatoshi Kudo
Masatoshi Kudo
SSShuichiro Shiina
Shuichiro Shiina
TMToshihiko Mizuta
Toshihiko Mizuta
MOMasao Omata
Masao Omata
Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, even after curative treatment. Vitamin K2, which has been reported to reduce HCC development, may be effective in preventing HCC recurrence. Patients who underwent curative ablation or resection of HCC were randomly assigned to receive placebo, 45 mg/day, or 90 mg/day vitamin K2 in double-blind fashion. HCC recurrence was surveyed every 12 weeks with dynamic computed tomography/magnetic resonance imaging, with HCC-specific tumor markers monitored every 4 weeks. The primary aim was to confirm the superiority of active drug to placebo concerning disease-free survival (DFS), and the secondary aim was to evaluate dose-response relationship. Disease occurrence and death from any cause were treated as events. Hazard ratios (HRs) for disease occurrence and death were calculated using a Cox proportional hazards model. Enrollment was commenced in March 2004. DFS was assessed in 548 patients, including 181 in the placebo group, 182 in the 45-mg/day group, and 185 in the 90-mg/day group. Disease occurrence or death was diagnosed in 58, 52, and 76 patients in the respective groups. The second interim analysis indicated that vitamin K2 did not prevent disease occurrence or death, with an HR of 1.150 (95% confidence interval: 0.843-1.570, one-sided; P = 0.811) between the placebo and combined active-drug groups, and the study was discontinued in March 2007. Conclusion: Efficacy of vitamin K2 in suppressing HCC recurrence was not confirmed in this double-blind, randomized, placebo-controlled study. (Hepatology 2011;)

17 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
KHKentaro Hata
Kentaro Hata
HIHiroshi Ikeda
Hiroshi Ikeda
YNYuki Nagamatsu
Yuki Nagamatsu
CMChihiro Masaki
Chihiro Masaki
RHRyuji Hosokawa
Ryuji Hosokawa
HSHiroshi Shimizu
Hiroshi Shimizu
Poly(methyl methacrylate) (PMMA) is widely used in dental applications. However, PMMA specialized for stereolithography (SLA) additive manufacturing (3D-printing) has not been developed yet. This study aims to develop a novel PMMA-based resin for SLA 3D-printing by mixing methyl methacrylate (MMA), ethylene glycol dimethacrylate (EGDMA), and PMMA powder in various mixing ratios. The printability and the viscosity of the PMMA-based resins were examined to determine their suitability for 3D-printing. The mechanical properties (flexural strength and Vickers hardness), shear bond strength, degree of conversion, physicochemical properties (water sorption and solubility), and cytotoxicity for L929 cells of the resulting resins were compared with those of three commercial resins: one self-cured resin and two 3D-print resins. EGDMA and PMMA were found to be essential components for SLA 3D-printing. The viscosity increased with PMMA content, while the mechanical properties improved as EGDMA content increased. The shear bond strength tended to decrease as EGDMA increased. Based on these characteristics, the optimal composition was determined to be 30% PMMA, 56% EGDMA, 14% MMA with flexural strength (84.6 ± 7.1 MPa), Vickers hardness (21.6 ± 1.9), and shear bond strength (10.5 ± 1.8 MPa) which were comparable to or higher than those of commercial resins. The resin’s degree of conversion (71.5 ± 0.7%), water sorption (19.7 ± 0.6 μg/mm3), solubility (below detection limit), and cell viability (80.7 ± 6.2% at day 10) were all acceptable for use in an oral environment. The printable PMMA-based resin is a potential candidate material for dental applications.

1 June 2016 in Chemical Engineering Science
Verified
Journal Article
Closed access
HIHiroshi Ikeda
Hiroshi Ikeda
SNSoichiro Nikata
Soichiro Nikata
EHErika Hirakawa
Erika Hirakawa
ATAkinori Tsuchida
Akinori Tsuchida
NMNorio Miura
Norio Miura

10 March 2016 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
NMNorio Miura
Norio Miura
HIHiroshi Ikeda
Hiroshi Ikeda
ATAkinori Tsuchida
Akinori Tsuchida

9 April 2023 in Polymers
Verified
Journal Article
Open access
PDF file
KHKentaro Hata
Kentaro Hata
YKYuya Komagata
Yuya Komagata
YNYuki Nagamatsu
Yuki Nagamatsu
CMChihiro Masaki
Chihiro Masaki
RHRyuji Hosokawa
Ryuji Hosokawa
HIHiroshi Ikeda
Hiroshi Ikeda
Poly-ether-ether-ketone (PEEK) is commonly employed in dental prostheses owing to its excellent mechanical properties; however, it is limited by its low bond strength with dental resin cement. This study aimed to clarify the type of resin cement most suitable for bonding to PEEK: methyl methacrylate (MMA)-based resin cement or composite-based resin cement. For this purpose, two MMA-based resin cements (Super-Bond EX and MULTIBOND II) and five composite-based resin cements (Block HC Cem, RelyX Universal Resin Cement, G-CEM LinkForce, Panavia V5, and Multilink Automix) were used in combination with appropriate adhesive primers. A PEEK block (SHOFU PEEK) was initially cut, polished, and sandblasted with alumina. The sandblasted PEEK was then bonded to resin cement with adhesive primer according to the manufacturer’s instructions. The resulting specimens were immersed in water at 37 °C for 24 h, followed by thermocycling. Subsequently, the tensile bond strengths (TBSs) of the specimens were measured; the TBSs of the composite-based resin cements after thermocycling were found to be zero (G-CEM LinkForce, Panavia V5, and Multilink Automix), 0.03 ± 0.04 (RelyX Universal Resin Cement), or 1.6 ± 2.7 (Block HC Cem), whereas those of Super-Bond and MULTIBOND were 11.9 ± 2.6 and 4.8 ± 2.3 MPa, respectively. The results demonstrated that MMA-based resin cements exhibited stronger bonding to PEEK than composite-based resin cements.